- Market Realist•2 days ago
Among the 24 analysts surveyed by Bloomberg for AbbVie (ABBV), 54.5% gave it “buy” ratings, and 40.9% gave it “hold” ratings.
- The Wall Street Journal•2 days ago
Pfizer’s $14 billion deal to buy Medivation and its prostate-cancer drug Xtandi is the latest in a long line of big pharmaceutical company acquisitions of smaller companies with prized assets. Here is ...
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||109.55 x 300|
|Ask||112.19 x 300|
|Day's Range||110.08 - 115.49|
|52wk Range||93.05 - 128.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||46.75|
|Avg Vol (3m)||4,503,971|
|Dividend & Yield||N/A (N/A)|